Validation of the P21-Activated Kinases as Targets for Inhibition in Neurofibromatosis Type 2
Cancer Research - United States
doi 10.1158/0008-5472.can-08-0866
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2008
Authors
Publisher
American Association for Cancer Research (AACR)